Dabrafenib in Treating Patients With Solid Tumors and Kidney or Liver Dysfunction

Clinical trial NCT01907802 · TERMINATED

Trial details

NCT number: NCT01907802
Sponsor: National Cancer Institute (NCI)
Status: TERMINATED
Phase: Phase 1
Study type: INTERVENTIONAL

BRAF Gene Mutation Hepatic Complication Renal Failure Solid Neoplasm

Start date: 2013-08-23
Primary completion: 2015-12-16
Enrollment: 8

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.